Hoya Corp. Invests Equity in LifeSpex
KIRKLAND, Wash., April 21 -- LifeSpex Inc. and Hoya Corp. report that Hoya Holdings Inc. has made a strategic equity investment in LifeSpex Corp. LifeSpex develops bio-photonics to provide point-of-care diagnostic systems for the detection of epithelial cancers. The company will use the investment proceeds to complete pivotal clinical trials for its Cerviscan product in the United States and Europe and to establish manufacturing capacity for early production shipments.
The Cerviscan system uses Evoked Tissue Fluorescence technology to enable physicians to directly assess and locate patients' cervical precancers and cancers in an office environment. LifeSpex Corp. has over 15 issued and blocking patents and patent applications in collaboration with the University of Texas at Austin.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024